IMUN news

The specific text for Exhibit 10.1 was not provided in the request. Analysis could not be completed based on available data.

Imunon, Inc. filed an amended version of its 2018 Stock Incentive Plan, which provides equity-based compensation to employees, directors, and consultants. The plan amendment is relevant as it governs the company's ability to attract and retain talent through stock awards.

Imunon's board approved a Certificate of Designation for Series A Preferred Stock on May 29, 2026, authorizing 400 shares with par value of $0.01 per share. The filing establishes the framework for preferred equity issuance but no shares have been issued to date.